期刊文献+

^18F-FDG-PET在妊娠绒毛膜癌临床诊疗中的应用

Clinical value of ^(18)F-deoxyglucose positron emission tomography/computer tomography in diagnosis and treatment of choriocarcinoma
下载PDF
导出
摘要 目的探讨18F-脱氧葡萄糖正电子发射显影/电子计算机断层扫描成像(18F-FDG-PET)在妊娠绒毛膜癌临床诊疗中的应用价值。方法对2例妊娠绒毛膜癌患者多次同时行18F-FDG-PET检查与动态血绒毛膜促性腺激素(β-HCG)监测,分析双肺、肝脏及盆腔的代谢异常增高转移性病变情况。结果 1例患者发现双肺、肝脏及盆腔多处转移病灶,经EMACO方案化疗后动态血β-HCG渐转正常,18F-FDG-PET显示多处病灶趋渐转阴。另1例经化疗后复发,18F-FDG-PET显示原发癌灶无活性,但血β-HCG稍增高,行子宫全切除术,病理诊断提示妊娠绒毛膜癌,活性细胞存在,判定18F-FDG-PET呈假阴性。术后持续随访,血β-HCG均为阴性。结论18F-FDG-PET在妊娠绒毛膜癌临床诊疗中了解原发灶与转移灶特点,评估癌细胞活性具有较高的应用价值。结合血β-HCG监测,可降低18F-FDG-PET假阳性和假阴性,为临床上妊娠绒毛膜癌的诊疗提供可靠依据。 Objective To investigate the clinical value of 18SF-deoxyglucose positron emission tomography/computer tomo- graphy (18SF-FDG-PET) in diagnosis and treatment of chorioearcinoma. Methods The lSF-FDG-PET with simultaneously monitoring serum beta-human chorionic gonadotrophin (β-HCG) was carried out on 2 cases with ehorioearcinoma. The increased metabolic abnor- malities in metastatic lesions of lung, liver and pelvic were observed. Results In one patient, is F-FDG-PET revealed the primary eho- riocarcinoma associated with pulmonary, liver and pelvis cavity metastases. The level of serum J3-HCG decreased to normal level gradu- ally and the SUVs of multiple lesions followed a normal distribution after EMA-CO chemotherapy. For another recurrence patient, serum 13-HCG increased and pathology diagnosis revealed that few viable cells existed by undergoing radical hysterectomy, but ISF-FDG-PET detected no uptake. Conclusion lSF-FDG-PET is useful in diagnosis and treatment of choriocareinoma by detecting the primary and metastasis sites, and possesses higher value in assessing eytoaetive. Simultaneously monitoring serum β-HCG can decrease the false positive rate and false negative rate of iSF-FDG-PET.
出处 《临床肿瘤学杂志》 CAS 2014年第2期160-163,共4页 Chinese Clinical Oncology
关键词 妊娠绒毛膜癌 正电子发射断层 计算机断层 绒毛膜促性腺激素 Choriocarcinoma 18F-deoxyglucose positron emission tomography/computer tomography (~aF_FDG_PET) Beta-human chorionic gonadotrophin(I3-HCG)
  • 相关文献

参考文献17

  • 1Natalia B, Pei H. Gestational trophoblastic disease: histopatho- logical diagnosis in the molecular era[ Jl. Diagnostic Histopathol- ogy, 2010, 16(11) :526-537.
  • 2Smith HO, Kohom E, Cole LA. Choriocarcinoma and gestational trophoblastic disease[ J]. Obstet Gynecol Clin North Am, 2005, 32(4) :661-684.
  • 3Fortes DL, Allen MS, Lowe VJ, et al. The sensitivity of 18F-flu- orodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules [ J ]. Eur J Cardiothorac Surg, 2008, 34(6) : 1223-1227.
  • 4Chang TC ,Yen TC, Li YT, et al. The role of 18F-fliorodeoxyglu- cose positron emission tomography in gestational trophoblastic tumours:a pilot study[J]. Eur J Nucl Med Mol Imaging, 2006, 33(2) : 156-163.
  • 5Sironi S, Picchio M, Mangili G, et al. 18F-fliorodeoxyglucose positron emission tomography as useful indicator of metastatic ges- tational trophoblastic tumor: preliminary results in three patients [J]. Gynecol Oncol, 2003, 91(1) :226-230.
  • 6Dhillon T, Palmieri C, Sebire NJ, et al. Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia[ J ]. J Reprod Med, 2006, 51 ( 11 ) : 879- 887.
  • 7Chang WC, Hung YC, Shen HP, et al. Choriocarcinoma with pulmonary metastasis: report of a case of successful treatment with serial FDG-PET follow-up [ J ]. J Reprod Med, 2007, 52 (5) :450-452.
  • 8Allen SD, Lira AK, Seckl MJ, et al. Radiology of gestational trephoblastic neoplasia[ J] .Clin Radiol, 2006, 61 (4) : 301-313.
  • 9Numnum TM, Leath CA 3rd, Straughn JM Jr, et al. Occult eho- discovered by positron emission tomography/ computed tomography imaging following a successful pregnancy [J]. Gynecol Oncol, 2005, 97(2):713-715.
  • 10Yen TC, Lai CH. Positron emission tomography in gynecologic cancer[J].Semin Nucl Med, 2006, 36(1) :93-104.

二级参考文献14

  • 1吴湖炳,王全师,王明芳,王欣璐,郭晓君.呋塞米介入试验在泌尿生殖系统肿瘤^(18)F-FDG PET/CT显像中的应用[J].中华核医学杂志,2005,25(4):206-208. 被引量:23
  • 2Even-Sapir E, Metser U, Flusser G, et al. Assessment of malignant skeletal disease: initial experience with ^18F-fluoride PET/ CT and comparison between ^18F-fluoride PET and ^18F-fluoride PET/CT[ J]. J Nucl Med, 2004,45:272-278.
  • 3Grahek D, Montravers F, Kerrou K, et al. ^18 F-FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management [ J ]. Eur J Nucl Med Mol Imaging,2004,31 (2) : 179-188.
  • 4Arulampalam THA, Costa DC, Loizidou M, et al. The role of positron emission tomography in the management of coloreetal cancer[J]. Br J Surg, 2001,88 : 1-14.
  • 5Havrilesky LI,Wong TZ,Sccord AA,et al. The role of PET scanning in the detection of recurrent cervical cancer [ J ]. Gyneeol Oncol, 2003,90 : 186-! 90.
  • 6Sakurai H, Suzuki Y, Nonaka T, et al. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy-tumor volume and FDG uptake value [ J ]. Gynecol Oncol ,2006,100:601-607.
  • 7Unger JB, Ivy JJ, Connor P, et al. Detection of recurrent cervical cancer by wholc-body : FDG PET scan in asymptomatic and symptomatic women[ J]. Gynecol Oncol,2004,94:212-216.
  • 8Bristow RE, De Carmen MG, Pannu HK, et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreduc-tive surgery using combined PET/CT [ J ]. Gynecol Oncol, 2003, 90(3) : 519-528.
  • 9Grab D, Flock F, Stohr I, et al. Classification ofasymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography[ J]. Gynecol Onco1,2000 ,77 :454- 459.
  • 10Nanni C ,Rubello D,Farsad M,et al. ^18F-FDG PET-CT in the evaluation of recurrent ovarian cancer : a prospective study on forty-one patients [ J ]. Eur J Surg Oncol, 2005,31 (7) :792 - 797.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部